The third major research study of the project

In the intervention study (IData study), the third stage of the i-PROGNOSIS project following the GData and SData studies, the acceptance, user-friendliness and feasibility of e-health supported interventions in Parkinson’s Disease (PD) patients is assessed.

The study has been validated by ethical authorities in Germany, Greece and the UK, the three countries where the study will be conducted. Read the ethical evaluation sheet in your language to learn more about the study, by clicking on the corresponding country below.


UK
UK
GR
Greece
DE
Germany

Who can participate?

PD patients who have the iPrognosis app are asked to participate in the IData study and to use the project’s e-health-supported interventions as often as possible for a period of four months.

Where does the study take place?

The majority of interventions are performed at home. Certain interventions requiring specialised motion sensors and large monitors, as well as all ExerGames, are going to be played in special “Game stations” in the clinics. Thus, patients will participate in biweekly therapy sessions, during dedicated visits planned together with the monitoring clinicians in Dresden, Thessaloniki and London.

Learn more about the technology involved in i-PROGNOSIS interventions
Learn more about the Adaptation Algorithms behind the games

How will we know if the interventions work?

To control for positive effects, three medical assessments are performed during this period (beginning – middle – end) in addition to an evaluation of the acceptance and compliance of the e-health-supported interventions.

In the long term, the aim is to complement the PD specialised physio-, occupational and speech therapy with e-health-supported therapies in the patient’s home. This is of particular importance as access to the medical care system, especially to therapeutic measures, is becoming more and more difficult, especially with older age and for patients living in rural areas. Therefore, e-health-supported therapies offer a promising alternative therapy method for PD patients.